| The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress K Dua, R Wadhwa, G Singhvi, V Rapalli, SD Shukla, MD Shastri, G Gupta, ... Drug development research 80 (6), 714-730, 2019 | 533 | 2019 |
| Functional effects of the microbiota in chronic respiratory disease KF Budden, SD Shukla, SF Rehman, KL Bowerman, S Keely, ... The Lancet Respiratory Medicine 7 (10), 907-920, 2019 | 322 | 2019 |
| Microbiome effects on immunity, health and disease in the lung SD Shukla, KF Budden, R Neal, PM Hansbro Clinical & Translational Immunology 6 (3), e133, 2017 | 319 | 2017 |
| Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease KL Bowerman, SF Rehman, A Vaughan, N Lachner, KF Budden, RY Kim, ... Nature communications 11 (1), 5886, 2020 | 231 | 2020 |
| Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations NK Jha, S Ojha, SK Jha, H Dureja, SK Singh, SD Shukla, DK Chellappan, ... Journal of Molecular Neuroscience, 1-18, 2021 | 152 | 2021 |
| Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis MD Shastri, SD Shukla, WC Chong, K Dua, GM Peterson, RP Patel, ... Oxidative Medicine and Cellular Longevity 2018, 2018 | 136 | 2018 |
| Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective R Vemuri, R Gundamaraju, MD Shastri, SD Shukla, K Kalpurath, M Ball, ... BioMed Research International 2018, 2018 | 136 | 2018 |
| Smoking and COVID-19: What we know so far MD Shastri, SD Shukla, WC Chong, KC Rajendra, K Dua, RP Patel, ... Respiratory medicine 176, 106237, 2021 | 125 | 2021 |
| Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems K Dua, V Malyla, G Singhvi, R Wadhwa, RV Krishna, SD Shukla, ... Chemico-biological interactions 299, 168-178, 2019 | 117 | 2019 |
| Microbiomes in respiratory health and disease: An Asia‐Pacific perspective SH Chotirmall, SL Gellatly, KF Budden, M Mac Aogáin, SD Shukla, ... Respirology 22 (2), 240-250, 2017 | 110 | 2017 |
| Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update M Mehta, DS Dhanjal, KR Paudel, B Singh, G Gupta, S Rajeshkumar, ... Inflammopharmacology 28, 795-817, 2020 | 106 | 2020 |
| Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction MQ Mahmood, SS Sohal, SD Shukla, C Ward, A Hardikar, WD Noor, ... International journal of chronic obstructive pulmonary disease, 1515-1524, 2015 | 93 | 2015 |
| Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches K Dua, VK Rapalli, SD Shukla, G Singhvi, MD Shastri, DK Chellappan, ... Biomedicine & Pharmacotherapy 107, 1218-1229, 2018 | 86 | 2018 |
| β-catenin, Twist and Snail: Transcriptional regulation of EMT in smokers and COPD, and relation to airflow obstruction MQ Mahmood, EH Walters, SD Shukla, S Weston, HK Muller, C Ward, ... Scientific reports 7 (1), 10832, 2017 | 82 | 2017 |
| Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders CA Alemao, KF Budden, HM Gomez, SF Rehman, JE Marshall, ... Allergy 76 (3), 714-734, 2021 | 78 | 2021 |
| An overview of vaccine development for COVID-19 SH Shahcheraghi, J Ayatollahi, AAA Aljabali, MD Shastri, SD Shukla, ... Therapeutic Delivery 12 (3), 235-244, 2021 | 70 | 2021 |
| The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL) SD Shukla, MQ Mahmood, S Weston, R Latham, HK Muller, SS Sohal, ... Respiratory research 18, 1-10, 2017 | 69 | 2017 |
| The role of environmental exposure to non-cigarette smoke in lung disease R Kc, SD Shukla, SS Gautam, PM Hansbro, RF O’Toole Clinical and translational medicine 7 (1), 39, 2018 | 67 | 2018 |
| TB meets COPD: An emerging global co-morbidity in human lung disease RF O'Toole, SD Shukla, EH Walters Tuberculosis 95 (6), 659-663, 2015 | 67 | 2015 |
| Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro KR Paudel, R Wadhwa, XN Tew, NJX Lau, T Madheswaran, ... Life Sciences 276, 119436, 2021 | 64 | 2021 |
Kamal DuaAssociate ProfessorVerified email at uts.edu.au
